| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | 10%+ Owner | Common Stock | 4,458,294 | $314,755,556 | $70.60 | 28 Mar 2025 | By Vivo Opportunity Fund Holdings, L.P. |
| Terns Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 4,023,741 | $24,947,194 | $6.20 | 03 Apr 2024 | By Vivo Opportunity Fund Holdings, L.P. |
| Terns Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 1,945,015 | $12,059,093 | $6.20 | 03 Apr 2024 | By: Vivo Capital Fund VIII, L.P. |
| Terns Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 268,573 | $1,665,153 | $6.20 | 03 Apr 2024 | By: Vivo Capital Surplus Fund VIII, L.P. |
| Sierra Oncology, Inc. | Director, 10%+ Owner | Common Stock | 0 | $55.00 | 01 Jul 2022 | By: Vivo Capital Fund IX, L.P. | |
| Sierra Oncology, Inc. | Director, 10%+ Owner | Common Stock | 0 | $55.00 | 01 Jul 2022 | By: Vivo Opportunity Fund Holdings, L.P. | |
| Sierra Oncology, Inc. | Director, 10%+ Owner | Common Stock | 0 | $55.00 | 01 Jul 2022 | By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | |
| Sierra Oncology, Inc. | Director, 10%+ Owner | Series A Warrants | 0 | 01 Jul 2022 | By: Vivo Capital Fund IX, L.P. | ||
| Sierra Oncology, Inc. | Director, 10%+ Owner | Series A Warrants | 0 | 01 Jul 2022 | By: Vivo Opportunity Fund Holdings, L.P. | ||
| Sierra Oncology, Inc. | Director, 10%+ Owner | Series A Warrants | 0 | 01 Jul 2022 | By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | 26 Mar 2025 | 3 | -$124,449,124 | 4 | 10%+ Owner | 28 Mar 2025, 19:03 |
| SLNO | SOLENO THERAPEUTICS INC | 27 Aug 2024 | 3 | -$49,210,750 | 4 | 10%+ Owner | 29 Aug 2024, 19:36 |
| SLNO | SOLENO THERAPEUTICS INC | 29 Apr 2024 | 2 | -$51,701,551 | 4 | 10%+ Owner | 01 May 2024, 13:10 |
| TERN | Terns Pharmaceuticals, Inc. | 01 Apr 2024 | 9 | -$2,796,859 | 4 | 10%+ Owner | 03 Apr 2024, 20:47 |
| SLNO | SOLENO THERAPEUTICS INC | 02 Oct 2023 | 2 | +$13,037,500 | 4 | 10%+ Owner | 04 Oct 2023, 16:30 |
| SLNO | SOLENO THERAPEUTICS INC | 26 Sep 2023 | 2 | +$5,605,413 | 4 | 10%+ Owner | 28 Sep 2023, 17:00 |
| SLNO | SOLENO THERAPEUTICS INC | 08 May 2023 | 0 | $0 | 3 | 10%+ Owner | 15 May 2023, 17:01 |
| TERN | Terns Pharmaceuticals, Inc. | 23 Dec 2022 | 1 | +$5,499,995 | 4 | 10%+ Owner | 23 Dec 2022, 16:48 |
| TERN | Terns Pharmaceuticals, Inc. | 07 Sep 2022 | 1 | +$2,160,000 | 4 | 10%+ Owner | 08 Sep 2022, 20:00 |
| TERN | Terns Pharmaceuticals, Inc. | 12 Aug 2022 | 4 | +$10,610,094 | 4 | 10%+ Owner | 16 Aug 2022, 20:44 |
| /report/000121390022036724-vivo-opportunity-llc-2022-07-01 | Sierra Oncology, Inc. | 01 Jul 2022 | 6 | -$183,123,160 | 4 | Director, 10%+ Owner | 01 Jul 2022, 16:59 |
| /report/000121390022004647-vivo-opportunity-llc-2022-01-31 | Sierra Oncology, Inc. | 31 Jan 2022 | 1 | +$21,600,000 | 4 | 10%+ Owner | 31 Jan 2022, 20:30 |
| /report/000121390022004318-vivo-opportunity-llc-2022-01-26 | Sierra Oncology, Inc. | 26 Jan 2022 | 6 | -$16,413,355 | 4 | 10%+ Owner | 28 Jan 2022, 19:12 |